Open AccessBuprenorphine: Not a silver bullet, and still controversial
Author(s) -
Sudheer Potru,
Michael Sprintz,
Antje Barreveld,
Lynn Kohan
Publication year - 2021
Publication title -
journal of opioid management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 39
eISSN - 2375-0146
pISSN - 1551-7489
DOI - 10.5055/jom.2021.0618
Subject(s) - buprenorphine , medicine , addiction medicine , addiction , pharmacy , substance abuse , psychiatry , alternative medicine , family medicine , medical emergency , opioid , receptor , pathology
We are practitioners of pain medicine and addiction medicine and also four of the seven members of the Multi-Society Ad Hoc Substance Use Disorder (SUD) Working Group comprised of representatives from anesthesia, pain, pharmacy, and addiction medicine societies. We are finalizing “tip sheets” and a consensus-based manuscript to provide guidance on the appropriate use and initiation of buprenorphine in the hospital setting by anesthesiologists, and in the outpatient setting by pain clinicians.